# ECOC (Abvc Biopharma, Inc.) - SEC EDGAR Financial Statements

> Abvc Biopharma, Inc. reported $296K in revenue and a net loss of $3.91M for the fiscal year ended December 31, 2025 (down 41.9% year over year), with a -1956.6% operating margin.

- Canonical: https://convexityos.com/fundamentals/ECOC
- Markdown: https://convexityos.com/fundamentals/ECOC.md
- SEC CIK: 0001173313
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 21, 2026, 05:02 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001173313&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | $296K | -41.9% YoY |
| Operating Income | FY 2025 | -$5.79M | -1956.6% margin |
| Net Income | FY 2025 | -$3.91M | -1322.6% net margin |
| Diluted EPS | FY 2025 | -$0.15 | Split-adjusted |
| Free Cash Flow | FY 2025 | -- | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $66K | Total debt: $1.71M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2017 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $296K | $510K | $152K | $970K | $356K | $483K | $702K | $7.0K | -- | -- |
| Cost of Revenue | -- | $763 | $302K | $286K | $5.1K | $19K | $20K | $185K | -- | -- |
| **Gross Profit** | -- | $509K | -$150K | $683K | $351K | $464K | $682K | -$178K | -- | -- |
| Research & Development | $121K | $179K | $1.06M | $2.69M | $1.00M | $550K | $1.05M | $989K | $3.17M | $3.15M |
| Selling, General & Admin | $2.89M | $2.26M | $5.37M | $6.07M | $5.75M | $4.27M | $3.07M | $1.59M | $812K | $707K |
| Total Operating Expenses | $7.15M | $5.21M | $6.62M | $15.80M | $12.06M | $8.97M | $4.14M | $2.61M | $4.14M | -- |
| **Operating Income** | -$7.15M | -$4.71M | -$6.77M | -$15.11M | -$11.71M | -$8.51M | -$3.46M | -$2.78M | -$4.14M | -$4.00M |
| **EBITDA** | -$7.13M | -$4.67M | -$6.74M | -$15.09M | -$11.69M | -$8.47M | -$3.40M | -$2.74M | -- | -- |
| Interest Income | $167K | $87K | $185K | $188K | $43K | $71K | $23K | $5.2K | $180 | $149 |
| Interest Expense | $416K | $826K | $1.31M | $294K | $227K | $405K | $482K | $463K | $103K | $75K |
| Income Before Tax | -$8.35M | -$5.37M | -$8.02M | -$15.51M | -$11.21M | -$10.81M | -$4.01M | -$6.43M | -$4.24M | -$4.07M |
| Income Tax Expense | $24K | -$111K | $256K | $798K | $825K | -$220K | -$77K | -$365K | $830 | $830 |
| **Net Income** | -$7.91M | -$4.90M | -$7.79M | -$16.42M | -$12.84M | -$10.59M | -$3.93M | -$6.06M | -$4.24M | -$4.07M |
| Basic EPS | -$0.39 | -$0.42 | -$1.80 | -$5.19 | -$5.10 | -$5.00 | -$2.10 | -$0.20 | -$0.20 | -$0.20 |
| **Diluted EPS** | -$0.39 | -$0.42 | -$1.80 | -$5.19 | -$5.10 | -$5.00 | -$2.10 | -$0.20 | -$0.20 | -$0.20 |
| Basic Shares Outstanding | 20.1M | 11.7M | 4.3M | 3.2M | 2.5M | 2.0M | 1.7M | 21.4M | 21.3M | 21.3M |
| Diluted Shares Outstanding | 20.1M | 11.7M | 4.3M | 3.2M | 2.5M | 2.0M | 1.7M | 21.4M | 21.3M | 21.3M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | -- | -- | -- | -- | $796K | -- | -- | $2.0K |
| Cost of Revenue | -- | -- | -- | -- | -- | -- | -- | $0 |
| **Gross Profit** | -- | -- | -- | -- | $796K | -- | -- | $2.0K |
| Research & Development | $18K | $23K | $33K | $29K | $30K | $33K | $29K | $32K |
| Selling, General & Admin | $377K | $504K | $752K | $784K | $798K | $690K | $615K | $311K |
| Total Operating Expenses | $1.24M | $780K | $1.57M | $2.20M | $1.96M | $2.29M | $693K | $707K |
| **Operating Income** | -$1.24M | -$780K | -$1.57M | -$2.20M | -$1.96M | -$2.29M | -$693K | -$705K |
| **EBITDA** | -$1.23M | -$767K | -$1.57M | -$2.19M | -$1.94M | -$2.28M | -$686K | -$694K |
| Interest Income | $2.4K | $683 | $3.8K | $82K | $47K | $19K | $19K | $12K |
| Interest Expense | $44K | $42K | $49K | $33K | $31K | $129K | $223K | $217K |
| Income Before Tax | -$1.39M | -$810K | -$1.69M | -$3.02M | -$2.08M | -$2.31M | -$944K | -$797K |
| Income Tax Expense | -- | -- | -- | -- | $527 | $24K | -- | -- |
| **Net Income** | $1.15M | -$737K | -$1.56M | -$2.77M | -$2.04M | -$2.26M | -$842K | -$732K |
| Basic EPS | $0.04 | -$0.03 | -$0.06 | -- | -$0.09 | -$0.13 | -$0.06 | -- |
| **Diluted EPS** | $0.04 | -$0.03 | -$0.06 | -- | -$0.09 | -$0.13 | -$0.06 | -- |
| Basic Shares Outstanding | 26.7M | 26.1M | 25.4M | -- | 23.3M | 17.4M | 15.0M | -- |
| Diluted Shares Outstanding | 26.7M | 26.1M | 25.4M | -- | 23.3M | 17.4M | 15.0M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2017 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $681K | $248K | $60K | $85K | $5.83M | $4.27M | $144K | $227K | $350K | $205K |
| Short-Term Investments | $64K | $65K | $79K | $76K | $108K | -- | -- | -- | -- | -- |
| **Cash & Short-Term Investments** | $746K | $313K | $139K | $161K | $5.94M | $4.27M | $144K | $227K | $350K | $205K |
| Accounts Receivable, Net | -- | -- | $1.5K | $98K | $281K | $160K | $164K | -- | -- | -- |
| Inventory | -- | -- | -- | -- | $26K | -- | -- | $1.3K | -- | -- |
| **Total Current Assets** | $3.26M | $2.18M | $1.66M | $2.99M | $7.65M | $6.17M | $878K | $566K | $2.64M | $2.75M |
| Property, Plant & Equipment, Net | $12.84M | $511K | $569K | $574K | $526K | $515K | $521K | $510K | -- | -- |
| Long-Term Investments | $1.88M | $2.26M | $2.53M | $842K | $933K | $1.19M | $3.36M | $3.49M | -- | -- |
| Other Non-Current Assets | $117K | $133K | $141K | -- | -- | -- | -- | -- | -- | -- |
| **Total Non-Current Assets** | $18.56M | $5.36M | $6.13M | $6.59M | $6.04M | $5.43M | $6.05M | $5.37M | $0 | $0 |
| **Total Assets** | $21.82M | $7.54M | $7.78M | $9.58M | $13.70M | $11.61M | $6.93M | $5.94M | $2.64M | $2.75M |
| Accounts Payable | -- | -- | -- | -- | -- | $23K | $24K | -- | -- | -- |
| Short-Term Debt | $756K | $840K | $899K | $1.89M | $1.64M | $1.63M | $1.92M | $899K | -- | -- |
| Deferred Revenue (Current) | $13K | $81K | $80K | $11K | -- | -- | -- | -- | -- | -- |
| Other Current Liabilities | -- | $773K | $173K | $360K | -- | -- | -- | -- | -- | -- |
| **Total Current Liabilities** | $6.92M | $6.56M | $6.10M | $5.54M | $3.69M | $4.84M | $6.81M | $10.99M | $4.40M | -- |
| Deferred Revenue (Non-Current) | -- | $296K | -- | -- | -- | -- | -- | -- | -- | -- |
| **Total Non-Current Liabilities** | $1.60M | $258K | $429K | $800K | $1.14M | $4.10M | $238K | $293K | $0 | -- |
| **Total Liabilities** | $8.52M | $6.82M | $6.53M | $6.34M | $4.83M | $8.94M | $7.05M | $11.28M | $4.40M | $4.15M |
| **Total Debt (incl. Leases)** | $2.67M | $1.48M | $1.71M | $2.11M | $1.99M | $1.95M | $2.46M | $899K | -- | -- |
| Common Stock | $25K | $14K | $7.9K | $3.3K | $29K | $24K | $19K | $12K | $214K | $214K |
| Retained Earnings | -$76.86M | -$68.95M | -$64.05M | -$54.90M | -$38.48M | -$25.64M | -$15.85M | -$12.21M | -$15.78M | -$15.40M |
| Accumulated Other Comp. Income | $488K | $446K | $516K | $517K | $540K | $565K | -- | -- | -- | -- |
| **Total Stockholders' Equity** | $11.11M | $1.23M | $1.55M | $3.10M | $8.84M | $3.44M | -$151K | -$5.66M | -$1.76M | -$1.39M |
| Total Equity | $13.30M | $724K | $1.25M | $3.24M | $8.87M | $2.66M | -$125K | -$5.34M | $703K | -$1.39M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $11K | $32K | $140K | $681K | $192K | $388K | $152K | $248K |
| Short-Term Investments | $55K | $62K | $62K | $64K | $65K | $65K | $65K | $65K |
| **Cash & Short-Term Investments** | $66K | $94K | $203K | $746K | $257K | $453K | $217K | $313K |
| Inventory | -- | -- | -- | -- | $11K | $11K | $11K | -- |
| **Total Current Assets** | $1.40M | $412K | $649K | $3.26M | $3.31M | $2.77M | $1.47M | $2.18M |
| Property, Plant & Equipment, Net | $12.83M | $12.83M | $12.82M | $12.84M | $12.85M | $8.22M | $8.17M | $511K |
| Long-Term Investments | $2.48M | $2.49M | $1.85M | $1.88M | $2.75M | $2.84M | $2.76M | $2.26M |
| Other Non-Current Assets | $107K | $107K | $106K | $117K | $117K | $141K | $127K | $133K |
| **Total Non-Current Assets** | $18.89M | $18.99M | $19.08M | $18.56M | $17.90M | $13.47M | $13.41M | $5.36M |
| **Total Assets** | $20.30M | $19.40M | $19.73M | $21.82M | $21.21M | $16.24M | $14.88M | $7.54M |
| Short-Term Debt | $30K | $59K | $89K | $756K | $809K | $872K | $801K | $840K |
| Deferred Revenue (Current) | $13K | $13K | $13K | $13K | $81K | $81K | $81K | $81K |
| Other Current Liabilities | -- | -- | -- | -- | $1.24M | $729K | -- | $773K |
| **Total Current Liabilities** | $7.19M | $5.69M | $5.39M | $6.92M | $6.54M | $6.53M | $6.73M | $6.56M |
| Deferred Revenue (Non-Current) | -- | -- | -- | -- | -- | -- | -- | $296K |
| **Total Non-Current Liabilities** | $1.36M | $1.44M | $1.51M | $1.60M | $176K | $219K | $189K | $258K |
| **Total Liabilities** | $8.55M | $7.13M | $6.90M | $8.52M | $6.72M | $6.75M | $6.92M | $6.82M |
| **Total Debt (incl. Leases)** | $1.71M | $1.82M | $1.93M | $2.67M | $1.18M | $1.33M | $1.33M | $1.48M |
| Common Stock | $27K | $26K | $26K | $25K | $24K | $20K | $15K | $14K |
| Retained Earnings | -$77.25M | -$79.16M | -$78.42M | -$76.86M | -$74.09M | -$72.05M | -$69.79M | -$68.95M |
| Accumulated Other Comp. Income | $515K | $498K | $500K | $488K | $487K | $484K | $444K | $446K |
| **Total Stockholders' Equity** | $13.05M | $10.29M | $10.77M | $11.11M | $12.06M | $7.01M | $5.40M | $1.23M |
| Total Equity | $11.74M | $12.27M | $12.83M | $13.30M | $14.50M | $9.49M | $7.96M | $724K |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2017 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$8.38M | -$5.26M | -$8.28M | -$16.31M | -$12.04M | -$10.59M | -$3.93M | -$6.06M | -$4.24M | -$4.07M |
| Depreciation & Amortization | $25K | $32K | $29K | $24K | $12K | $37K | $55K | $44K | -- | -- |
| Stock-Based Compensation | $4.14M | $2.77M | $186K | $7.04M | $5.31M | $4.15M | $22K | $29K | $155K | $138K |
| Change in Receivables | -- | -- | $229K | -$614K | -$121K | $3.7K | -$121K | $3.4K | -- | -- |
| Change in Inventory | -$11K | -- | -- | -- | -$26K | -- | $1.3K | $15K | -- | -- |
| Change in Payables | -- | -- | -- | -- | -$23K | -$951 | $50K | -$98K | -- | -$18K |
| **Operating Cash Flow** | -$2.99M | -$1.81M | -$4.19M | -$7.40M | -$7.60M | -$4.56M | -$3.13M | -$901K | -$1.49M | -$1.60M |
| Capital Expenditure | -- | -- | -$21K | -$120K | -$18K | -- | -- | -- | -- | -- |
| **Free Cash Flow** | -- | -- | -$4.21M | -$7.52M | -$7.62M | -- | -- | -- | -- | -- |
| Purchases of Investments | -- | -- | -- | -- | -$108K | -- | -$18K | -- | -- | -- |
| **Investing Cash Flow** | -$1.21M | -- | -$360K | -$1.72M | -$806K | -$225K | -$35K | -$156K | -- | -- |
| Common Stock Issued | -- | -- | $1.05M | $3.66M | $11.12M | $7.62M | $531K | -- | -- | -- |
| **Financing Cash Flow** | $4.64M | $1.98M | $3.87M | $4.01M | $10.00M | $9.57M | $3.09M | $897K | $1.56M | $1.63M |
| **Net Change in Cash** | $463K | $147K | -$675K | -$5.17M | $1.56M | $4.84M | -$82K | -$164K | $75K | $31K |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$1.39M | -$810K | -$1.69M | -$3.02M | -$2.08M | -$2.33M | -$944K | -$797K |
| Depreciation & Amortization | $6.9K | $12K | $5.8K | $5.8K | $25K | $14K | $7.0K | $10K |
| Stock-Based Compensation | $846K | $253K | $787K | $1.39M | $1.14M | $1.57M | $49K | $363K |
| Change in Inventory | -- | -- | -- | $0 | $0 | $0 | -$11K | -- |
| **Operating Cash Flow** | -$439K | -$244K | -$894K | -$588K | -$965K | -$894K | -$540K | -$702K |
| **Investing Cash Flow** | -$23K | -$102K | $47K | -- | -- | -- | -- | -- |
| **Financing Cash Flow** | $409K | $226K | -$342K | $1.08M | $1.20M | $1.93M | $429K | $336K |
| **Net Change in Cash** | -$21K | -$108K | -$1.19M | $473K | -$222K | $317K | -$104K | $94K |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2017 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | -- | 99.9% | -98.1% | 70.5% | 98.6% | 96.1% | 97.1% | -2563.6% | -- | -- |
| **Operating Margin** | -2416.0% | -923.3% | -4439.2% | -1558.5% | -3290.1% | -1760.9% | -492.9% | -40031.1% | -- | -- |
| **Net Profit Margin** | -2671.8% | -962.1% | -5109.3% | -1693.5% | -3608.5% | -2193.1% | -560.5% | -87184.2% | -- | -- |
| Return on Equity (ROE) | -71.2% | -399.9% | -501.1% | -530.0% | -145.2% | -308.1% | -- | -- | -- | -- |
| Return on Assets (ROA) | -36.2% | -65.0% | -100.0% | -171.4% | -93.7% | -91.3% | -56.8% | -102.1% | -160.5% | -147.8% |
| Current Ratio | 0.47x | 0.33x | 0.27x | 0.54x | 2.07x | 1.27x | 0.13x | 0.05x | 0.60x | -- |
| Quick Ratio | 0.11x | 0.05x | 0.02x | 0.05x | 2.07x | 0.92x | 0.05x | 0.05x | 0.08x | -- |
| Debt to Equity | 0.24x | 1.21x | 1.10x | 0.68x | 0.22x | 0.57x | -- | -- | -- | -- |
| **Revenue Growth (YoY)** | -41.9% | +234.3% | -84.3% | +172.6% | -26.3% | -31.2% | +9988.0% | -- | -- | -- |
| Gross Profit Growth (YoY) | -- | -- | -121.9% | +94.9% | -24.5% | -31.9% | -- | -- | -- | -- |
| 5Y Revenue / Share Growth | -94.0% | -89.1% | +10710.2% | -- | -- | -- | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | -- | -- | -- | -- | -- | -- | -- | 99.9% |
| **Operating Margin** | -- | -- | -- | -- | -- | -- | -- | -923.3% |
| **Net Profit Margin** | -- | -- | -- | -- | -- | -- | -- | -962.1% |
| Return on Equity (ROE) | -30.0% | -69.1% | -80.1% | -71.2% | -48.7% | -60.2% | -53.9% | -399.9% |
| Return on Assets (ROA) | -19.3% | -36.6% | -43.7% | -36.2% | -27.7% | -26.0% | -19.6% | -65.0% |
| Current Ratio | 0.20x | 0.07x | 0.12x | 0.47x | 0.51x | 0.42x | 0.22x | 0.33x |
| Quick Ratio | 0.01x | 0.02x | 0.04x | 0.11x | 0.50x | 0.42x | 0.22x | 0.05x |
| Debt to Equity | 0.13x | 0.18x | 0.18x | 0.24x | 0.10x | 0.19x | 0.25x | 1.21x |
| **Revenue Growth (YoY)** | -- | -- | -- | -- | +104.5% | -- | -- | -9.2% |
| Gross Profit Growth (YoY) | -- | -- | -- | -- | +104.6% | -- | -- | -- |
| Operating Cash Flow Growth (YoY) | -- | -- | -- | -- | -1701.7% | -- | -- | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
